INSPIRE VETERINARY PARTNE-A (IVP) Fundamental Analysis & Valuation
NASDAQ:IVP • US45784E3045
Current stock price
0.034 USD
-0.01 (-16.05%)
At close:
0.0305 USD
0 (-10.29%)
After Hours:
This IVP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IVP Profitability Analysis
1.1 Basic Checks
- In the past year IVP has reported negative net income.
- IVP had a negative operating cash flow in the past year.
- IVP had negative earnings in each of the past 5 years.
- In the past 5 years IVP always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -49.85%, IVP is doing worse than 86.41% of the companies in the same industry.
- The Return On Equity of IVP (-286.48%) is worse than 78.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.85% | ||
| ROE | -286.48% | ||
| ROIC | N/A |
ROA(3y)-55.06%
ROA(5y)-37.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- IVP has a Gross Margin of 19.36%. This is comparable to the rest of the industry: IVP outperforms 40.78% of its industry peers.
- IVP's Gross Margin has declined in the last couple of years.
- IVP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.18%
GM growth 5YN/A
2. IVP Health Analysis
2.1 Basic Checks
- IVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for IVP has been increased compared to 1 year ago.
- The debt/assets ratio for IVP has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -3.46, we must say that IVP is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of IVP (-3.46) is worse than 84.47% of its industry peers.
- A Debt/Equity ratio of 2.47 is on the high side and indicates that IVP has dependencies on debt financing.
- The Debt to Equity ratio of IVP (2.47) is worse than 73.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.47 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.46 |
ROIC/WACCN/A
WACC8.02%
2.3 Liquidity
- A Current Ratio of 0.39 indicates that IVP may have some problems paying its short term obligations.
- The Current ratio of IVP (0.39) is worse than 87.38% of its industry peers.
- IVP has a Quick Ratio of 0.39. This is a bad value and indicates that IVP is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.34, IVP is doing worse than 87.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.39 | ||
| Quick Ratio | 0.34 |
3. IVP Growth Analysis
3.1 Past
- IVP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.12%, which is quite impressive.
- Looking at the last year, IVP shows a decrease in Revenue. The Revenue has decreased by -8.77% in the last year.
- Measured over the past years, IVP shows a very strong growth in Revenue. The Revenue has been growing by 86.71% on average per year.
EPS 1Y (TTM)98.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.69%
Revenue 1Y (TTM)-8.77%
Revenue growth 3Y86.71%
Revenue growth 5YN/A
Sales Q2Q%6.6%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. IVP Valuation Analysis
4.1 Price/Earnings Ratio
- IVP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. IVP Dividend Analysis
5.1 Amount
- No dividends for IVP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IVP Fundamentals: All Metrics, Ratios and Statistics
0.034
-0.01 (-16.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner Change508.53%
Ins OwnersN/A
Ins Owner Change0%
Market Cap230.52K
Revenue(TTM)15.56M
Net Income(TTM)-11.94M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-25.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS2.29
BVpS0.61
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.85% | ||
| ROE | -286.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.36% | ||
| FCFM | N/A |
ROA(3y)-55.06%
ROA(5y)-37.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.18%
GM growth 5YN/A
F-Score4
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.47 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 8.76% | ||
| Cap/Sales | 0.69% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.39 | ||
| Quick Ratio | 0.34 | ||
| Altman-Z | -3.46 |
F-Score4
WACC8.02%
ROIC/WACCN/A
Cap/Depr(3y)26.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.77%
Revenue growth 3Y86.71%
Revenue growth 5YN/A
Sales Q2Q%6.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-565.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.26%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE VETERINARY PARTNE-A / IVP Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for INSPIRE VETERINARY PARTNE-A?
ChartMill assigns a fundamental rating of 1 / 10 to IVP.
What is the valuation status of INSPIRE VETERINARY PARTNE-A (IVP) stock?
ChartMill assigns a valuation rating of 0 / 10 to INSPIRE VETERINARY PARTNE-A (IVP). This can be considered as Overvalued.
How profitable is INSPIRE VETERINARY PARTNE-A (IVP) stock?
INSPIRE VETERINARY PARTNE-A (IVP) has a profitability rating of 0 / 10.
Can you provide the financial health for IVP stock?
The financial health rating of INSPIRE VETERINARY PARTNE-A (IVP) is 0 / 10.